Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health & Science University, Portland, OR 97239-3098, USA.
Virology. 2010 Jul 20;403(1):26-36. doi: 10.1016/j.virol.2010.03.027. Epub 2010 May 4.
Adeno-associated viruses (AAVs) are leading candidate vectors for human gene therapy. AAV serotypes have broad cellular tropism and use a variety of cellular receptors. AAV serotype 3 binds to heparan sulfate proteoglycan prior to cell entry and is serologically distinct from other serotypes. The capsid features that distinguish AAV-3B from other serotypes are poorly understood. The structure of AAV-3B has been determined to 2.6A resolution from twinned crystals of an infectious virus. The most distinctive structural features are located in regions implicated in receptor and antibody binding, providing insights into the cell entry mechanisms and antigenic nature of AAVs. We show that AAV-3B has a lower affinity for heparin than AAV-2, which can be rationalized by the distinct features of the AAV-3B capsid. The structure of AAV-3B provides an additional foundation for the future engineering of improved gene therapy vectors with modified receptor binding or antigenic characteristics.
腺相关病毒(AAV)是用于人类基因治疗的主要候选载体。AAV 血清型具有广泛的细胞嗜性,并使用多种细胞受体。AAV 血清型 3 在进入细胞之前与硫酸乙酰肝素蛋白聚糖结合,并且与其他血清型在血清学上不同。区分 AAV-3B 与其他血清型的衣壳特征尚不清楚。AAV-3B 的结构已从感染性病毒的孪晶晶体中以 2.6A 的分辨率确定。最独特的结构特征位于与受体和抗体结合相关的区域,为 AAV 进入细胞的机制和抗原特性提供了深入的了解。我们表明,AAV-3B 与 AAV-2 相比对肝素的亲和力较低,这可以通过 AAV-3B 衣壳的独特特征来合理化。AAV-3B 的结构为未来工程改造具有改良受体结合或抗原特性的改良基因治疗载体提供了额外的基础。